Get started
RocketTickers

Affimed Announces FDA Clearance of IND to Commence First-in-Huma

Long
Affimed N.V. (NASDAQ:AFMD)  
RocketTickers  
NASDAQ:AFMD   Affimed N.V.
Beyond Technical Analysis
5
0
beyondta
AFMD: Affimed N.V.
2019-11-07 16:01:00
Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.